Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
7.30
-0.24 (-3.18%)
At close: Oct 7, 2025, 4:00 PM EDT
7.30
0.00 (0.00%)
After-hours: Oct 7, 2025, 4:00 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $57.10 million as of October 7, 2025. Its market cap has decreased by -77.91% in one year.
Market Cap
57.10M
Enterprise Value
109.76M
1-Year Change
-77.91%
Ranking
Category
Stock Price
$7.30
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $57.10M, a decrease of -83.02%. That is a compound annual growth rate of -30.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 58.81M | -73.58% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
| Oct 28, 2020 | 336.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |